• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用高剂量和低剂量吐温-醚破坏的SIVMAC对恒河猴进行免疫接种。

Immunization of rhesus monkeys with high- and low-dose Tween-ether-disrupted SIVMAC.

作者信息

Voss G, Stahl-Hennig C, Petry H, Coulibaly C, Nick S, Fuchs D, Wachter H, Lüke W, Hunsmann G

机构信息

Deutsches Primatenzentrum, Abteilung Virologie und Immunologie, Göttingen, Germany.

出版信息

AIDS Res Hum Retroviruses. 1992 Aug;8(8):1397-400. doi: 10.1089/aid.1992.8.1397.

DOI:10.1089/aid.1992.8.1397
PMID:1466966
Abstract

Two vaccine trials were conducted with low- and high-dose purified Twen-ether-treated SIVmac adsorbed onto aluminum hydroxide using rhesus macaques. In the first experiment 7 macaques were immunized with a total amount of 560 micrograms protein and 3 animals served as controls. After the immunization period the vaccinees exhibited ELISA titers up to 1:1280 and 5 immunized animals showed an antigen-specific proliferative response. After the virus challenge the 3 control animals and 3 vaccinees became infected. Four of the infected animals developed a cytotoxic T-cell response beginning 8 weeks postchallenge. The 4 protected animals were rechallenged 16 weeks later and all became infected. For the high-dose experiment 5 immunized animals receiving 2 mg of antigen and 2 control animals were used. The ELISA titers of the vaccinees reached 1:20480 and 4 animals exhibited an antigen-specific proliferative response. In response to virus challenge the 2 control and 1 immunized animal became infected. From these data it can be concluded that the high-dose immunization scheme elicited higher antibody titers and increased the fraction of protected animals.

摘要

使用恒河猴对吸附于氢氧化铝上的低剂量和高剂量纯化双醚处理的SIVmac进行了两项疫苗试验。在第一个实验中,7只猕猴用总量为560微克蛋白质进行免疫,3只动物作为对照。免疫期后,疫苗接种者的ELISA滴度高达1:1280,5只免疫动物表现出抗原特异性增殖反应。病毒攻击后,3只对照动物和3只疫苗接种者被感染。4只受感染动物在攻击后8周开始产生细胞毒性T细胞反应。4只受保护的动物在16周后再次受到攻击,全部被感染。在高剂量实验中,使用了5只接受2毫克抗原的免疫动物和2只对照动物。疫苗接种者的ELISA滴度达到1:20480,4只动物表现出抗原特异性增殖反应。针对病毒攻击,2只对照动物和1只免疫动物被感染。从这些数据可以得出结论,高剂量免疫方案引发了更高的抗体滴度,并增加了受保护动物的比例。

相似文献

1
Immunization of rhesus monkeys with high- and low-dose Tween-ether-disrupted SIVMAC.用高剂量和低剂量吐温-醚破坏的SIVMAC对恒河猴进行免疫接种。
AIDS Res Hum Retroviruses. 1992 Aug;8(8):1397-400. doi: 10.1089/aid.1992.8.1397.
2
Immunization with tween-ether-treated SIV adsorbed onto aluminum hydroxide protects monkeys against experimental SIV infection.用吸附在氢氧化铝上的吐温 - 醚处理的猴免疫缺陷病毒(SIV)进行免疫接种可保护猴子免受实验性SIV感染。
Virology. 1992 Feb;186(2):588-96. doi: 10.1016/0042-6822(92)90025-k.
3
Potential significance of the cellular immune response against the macaque strain of simian immunodeficiency virus (SIVMAC) in immunized and infected rhesus macaques.针对猿猴免疫缺陷病毒(SIVMAC)猕猴株的细胞免疫反应在免疫和感染的恒河猴中的潜在意义。
J Gen Virol. 1992 Sep;73 ( Pt 9):2273-81. doi: 10.1099/0022-1317-73-9-2273.
4
Vaccine protection of rhesus macaques against simian immunodeficiency virus infection.恒河猴针对猿猴免疫缺陷病毒感染的疫苗保护作用。
AIDS Res Hum Retroviruses. 1990 Nov;6(11):1239-46. doi: 10.1089/aid.1990.6.1239.
5
A formalin inactivated whole SIVmac vaccine in Ribi adjuvant protects against homologous and heterologous SIV challenge.
J Med Primatol. 1992 Feb-May;21(2-3):108-12.
6
Comparison of protection afforded by whole virus ISCOM versus MDP adjuvanted formalin-inactivated SIV vaccines from IV cell-free or cell-associated homologous challenge.全病毒免疫刺激复合物(ISCOM)与含胞壁酰二肽(MDP)佐剂的福尔马林灭活猴免疫缺陷病毒(SIV)疫苗对无细胞或细胞相关同源性静脉内攻击的保护作用比较。
AIDS Res Hum Retroviruses. 1992 Aug;8(8):1507-10. doi: 10.1089/aid.1992.8.1507.
7
Specific and non-specific immunity and protection of macaques against SIV infection.
Vaccine. 1992;10(12):873-9. doi: 10.1016/0264-410x(92)90052-l.
8
SIV vaccine protection of rhesus monkeys.
Biotechnol Ther. 1991;2(1-2):9-19.
9
Protection of monkeys by a split vaccine against SIVmac depends upon biological properties of the challenge virus.一种针对猴免疫缺陷病毒(SIVmac)的裂解疫苗对猴子的保护作用取决于攻击病毒的生物学特性。
AIDS. 1993 Jun;7(6):787-95. doi: 10.1097/00002030-199306000-00005.
10
Vaccine studies with the 32H reisolate of SIVmac251: an overview.用SIVmac251的32H再分离株进行的疫苗研究:概述
AIDS Res Hum Retroviruses. 1992 Aug;8(8):1479-81. doi: 10.1089/aid.1992.8.1479.

引用本文的文献

1
Identification of the V1 region as a linear neutralizing epitope of the simian immunodeficiency virus SIVmac envelope glycoprotein.将V1区域鉴定为猿猴免疫缺陷病毒SIVmac包膜糖蛋白的线性中和表位。
J Virol. 1997 Dec;71(12):9475-81. doi: 10.1128/JVI.71.12.9475-9481.1997.
2
Incomplete protection, but suppression of virus burden, elicited by subunit simian immunodeficiency virus vaccines.亚单位猿猴免疫缺陷病毒疫苗引发的不完全保护,但可抑制病毒载量。
J Virol. 1994 Mar;68(3):1843-53. doi: 10.1128/JVI.68.3.1843-1853.1994.
3
Macaques immunized with HLA-DR are protected from challenge with simian immunodeficiency virus.
用HLA - DR免疫的猕猴可免受猿猴免疫缺陷病毒攻击。
J Virol. 1995 May;69(5):3117-24. doi: 10.1128/JVI.69.5.3117-3124.1995.